The tantalizing prospect of deciphering the precise crosstalk between TLR-9-mediated signaling and EBV infection holds the potential to unravel new avenues for therapeutic strategies tailored to the unique molecular milieu of GC. Here, TLR9 is linked to Epstein-Barr virus infection.